Car T Cell Therapy Market Size And Share

  • Report Code : TIPRE00029935
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

CAR-T Cell Therapy Market Share and Business Opportunities 2030

Buy Now

CAR-T Cell Therapy Market Report CAR-T Cell Therapy Market Scope and Analysis CAR-T Cell Therapy Market Size and Share

CAR-T Cell Therapy Market: Strategic Insights

CAR-T Cell Therapy Market

  • CAGR (2022 - 2030)
    17.5%
  • Market Size 2022
    US$ 2.79 Billion
  • Market Size 2030
    US$ 10.13 Billion

Market Dynamics

GROWTH DRIVERS
  • Increase in cancer incidence rates
  • Advancements in cell therapy technologies
  • Growing demand for personalized treatment options
FUTURE TRENDS
  • Increasing approval and adoption of CAR T-cell therapies
  • Technological advancements in immunotherapies for cancer treatment
  • Rising demand for personalized cancer treatments and therapies
OPPORTUNITIES
  • Growing demand for personalized cancer treatments
  • Advances in CAR T-cell therapy for oncology
  • Increasing approval of CAR T-cell therapies for cancers

Key Players

  • Bristol Myers Squibb Company
  • Novartis AG
  • Gilead Sciences Inc
  • Johnson Johnson Services Inc
  • CARsgenTherapeutics Co Ltd
  • Aurora Biopharma
  • Legend Biotech
  • Pfizer Inc
  • bluebird bio Inc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Targeted Antigen
  • CD19 and BCMA
Indication
  • Lymphomas
  • Leukemia
  • Multiple Myeloma
End User
  • Hospitals and Specialty Clinics
  • Ambulatory Surgical Centers